Insulin Glargine
These highlights do not include all the information needed to use INSULIN GLARGINE-YFGN safely and effectively. See full prescribing information for INSULIN GLARGINE-YFGN. INSULIN GLARGINE-YFGN injection, for subcutaneous useInitial U.S. Approval: 2021
3ac85ebb-5594-59c8-77fd-df254329d151
HUMAN PRESCRIPTION DRUG LABEL
Jul 28, 2023
Biocon Biologics Inc.
DUNS: 117609395
Products 2
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
insulin Glargine-yfgn
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (7)
insulin Glargine-yfgn
Product Details
FDA regulatory identification and product classification information